Karuna Therapeutics Inc (DELISTED) (KRTX:DL)
329.83
0.00 (0.00%)
USD |
NASDAQ |
Mar 18, 16:00
Karuna Therapeutics Cash from Operations (Quarterly): -111.06M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -111.06M |
| September 30, 2023 | -110.00M |
| June 30, 2023 | -64.13M |
| March 31, 2023 | -100.63M |
| December 31, 2022 | -78.76M |
| September 30, 2022 | -59.95M |
| June 30, 2022 | -39.50M |
| March 31, 2022 | -49.80M |
| December 31, 2021 | -6.998M |
| September 30, 2021 | -43.81M |
| June 30, 2021 | -28.89M |
| March 31, 2021 | -21.18M |
| Date | Value |
|---|---|
| December 31, 2020 | -22.94M |
| September 30, 2020 | -22.78M |
| June 30, 2020 | -15.79M |
| March 31, 2020 | -8.341M |
| December 31, 2019 | -6.82M |
| September 30, 2019 | -8.416M |
| June 30, 2019 | -9.573M |
| March 31, 2019 | -6.114M |
| December 31, 2018 | -6.864M |
| September 30, 2018 | -2.131M |
| June 30, 2018 | -5.681M |
| March 31, 2018 | -0.701M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-111.06M
Minimum
Dec 2023
-6.82M
Maximum
Dec 2019
-42.60M
Average
-28.89M
Median
Jun 2021
Cash from Operations (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 2.834B |
| RayzeBio inc (DELISTED) | -45.26M |
| Icosavax Inc (DELISTED) | -18.97M |
| Madrigal Pharmaceuticals Inc | -79.93M |
| Theseus Pharmaceuticals Inc (DELISTED) | -11.03M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | 92.44M |
| Cash from Financing (Quarterly) | 19.87M |
| Free Cash Flow | -388.74M |
| Free Cash Flow Per Share (Quarterly) | -2.96 |
| Free Cash Flow Yield | -3.19% |